ENTITY
Zai Lab Ltd

Zai Lab Ltd (ZLAB US)

131
Analysis
Health CareChina
Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.
more
Refresh
bullishBaozun Inc.
17 Sep 2020 15:47

Baozun HK Secondary Listing - Large Dilution Needs a Large Correction

Zai Lab Ltd (ZLAB US) plans to raise around US$1bn in its secondary listing in Hong Kong. We have covered the company's listing and some of its...

Logo
357 Views
Share
bullishZai Lab Ltd
14 Sep 2020 17:20

Zai Lab HK Secondary Listing - Large Deal to Digest but past Deals Have Done Well

ZTO Express (ZTO US) plans to raise around US$2bn in its secondary listing in Hong Kong. While the company filed its PHIP on Friday, 11th Sep...

Logo
394 Views
Share
bearishS&P 500 INDEX
22 Apr 2020 08:38

U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely

Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...

Logo
440 Views
Share
bearishMSCI ACWI Index
27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
446 Views
Share
20 Mar 2020 04:41

Dollar Surge Further Aggravates Equity Markets

Support levels have meant little more than talking points as indexes are slicing through them like butter. The truth remains that no one knows how...

Logo
431 Views
Share
x